Thryv Therapeutics Inc., a clinical-stage biotechnology company advancing novel serum glucocorticoid inducible kinase 1 (SGK1 ...
Bitcoin has remained uncorrelated with the global M2 money supply since mid-2025, and the prolonged divergence has fueled ...
Bitcoin’s (BTC) 52-week correlation with gold reached zero for the first time since mid-2022 and may turn negative by the end ...
The food-focused format, which will debut in Crestwood, Missouri, is about 1,000 square feet larger than the retailer’s ...
QuikTrip continues to expand outside of Missouri, too. In 2025, it opened its newest travel center in Daleville, Indiana, its ...
The Emperor Penguin has a go… just for fun Perhaps the most famous low-level systems programmer has tried "vibe coding" for ...
Program will expand access in certain regions where Revuforj is not available commercially, as permitted by local regulations -- Program will ...
Discover why top firms are offering fresh IIT graduates salaries exceeding ₹2 crores and how students can prepare for these ...
WAKIX 2025 Preliminary Net Revenue of ~$868 Million; 2026 WAKIX Net Revenue Guidance of $1.0 – $1.04 Billion on Track for Blockbuster Status in NarcolepsyOn Track to Extend the Pitolisant Franchise ...
The diagnosis and management of invasive fungal infections in adult patients with hematological malignancies remains a ...
Launched KOMZIFTI™ (ziftomenib), first and only once-daily, oral menin inhibitor approved for adults with R/R NPM1-mutated AML – – $2.1 million ...